
HQ: South San Francisco, California, United States
About Theravance Biopharma Company
Theravance Biopharma is a biopharmaceutical company with one approved product.
Theravance Biopharma Specialization
Pharmaceuticals, Biotechnology, Healthcare & Medical
Theravance Biopharma General Information
HQ: South San Francisco, California, United States
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Equity
Founded Date: 1996
Company Type: For Profit
Stock Symbol: NASDAQ:TBPH
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: (650)808-4045
Last Investment Activity: Jan 16, 2024
Investments Activity: Jan 16, 2024 Dec 21, 2023 Aug 29, 2023
Theravance Biopharma Email Format
{first_letter_first_name}{last_name}@theravance.com — 100.0% (example: ssmith@domain.com)
Theravance Biopharma General Theravance Biopharma Emails
-
General Inquiries
medinfo@theravance.com
-
General Press Inquiries
cypress@theravance.com
-
Investor Relations
investor.relations@theravance.com
Contact details of 5 Theravance Biopharma executives
Christopher Porter
-
Work email
c*****r@theravance.com
Jesse Fecker
-
Work email
j*****r@theravance.com
Contact details of 3 Theravance Biopharma other employees
-
Work email
k****a@theravance.com
Similar Companies like Theravance Biopharma

HQ: North Chicago, Illinois, United States
AbbVie is a pharmaceutical company that discovers, develops,...
HQ: North Chicago, Illinois, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 22, 2024
Founded Date: 2013
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NYSE:ABBV
Operating Status: Active

HQ: New York, New York, United States
Pfizer is a biopharmaceutical company that provides affordab...
HQ: New York, New York, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Sep 3, 2024
Venture Stage: Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Seed, Venture
Founded Date: 1849
Number of Exits: 19
Company Type: For Profit
Stock Symbol: NYSE:PFE
Operating Status: Active
Investor Type: Corporate Venture Capital, Venture Capital

HQ: Rahway, New Jersey, United States
Merck is a biopharmaceutical company that offers medicines a...
HQ: Rahway, New Jersey, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 28, 2024
Founded Date: 1891
Number of Exits: 9
Company Type: For Profit
Stock Symbol: NYSE:MRK
Operating Status: Active
Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.